SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-061275
Filing Date
2024-05-17
Accepted
2024-05-16 18:56:31
Documents
12
Period of Report
2024-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20240515.htm   iXBRL 8-K 85736
2 EX-10.1 cytk-ex10_1.htm EX-10.1 121560
  Complete submission text file 0000950170-24-061275.txt   341058

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20240515.xsd EX-101.SCH 25032
15 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20240515_htm.xml XML 4753
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 24957279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)